Discovery and development of a novel class of phenoxyacetyl amides as highly potent TRPM8 agonists for use as cooling agents

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3931-3938. doi: 10.1016/j.bmcl.2017.04.003. Epub 2017 Apr 11.

Abstract

The paper presents the activity trends for a novel series of phenoxyacetyl amides as human TRPM8 receptor agonists. This series encompasses in vitro activity values ranging from the micromolar to the picomolar levels. Sensory evaluation of these molecules highlights their relevance as cooling agents for oral applications. The positive outcome of the complete evaluation of N-(1H-pyrazol-3-yl)-N-(thiophen-2-ylmethyl)-2-(p-tolyloxy)acetamide resulted in its approval for Generally Recognized As Safe (GRAS) status by the Flavor & Extract Manufacturer Association (FEMA) as FEMA 4809.

Keywords: Chemesthesis; Coolants; Cooling agents; FEMA 4809; Menthol; TRPM8 agonists; WS-3.

MeSH terms

  • Amides / chemical synthesis
  • Amides / chemistry
  • Amides / pharmacology*
  • Cryoprotective Agents / chemical synthesis
  • Cryoprotective Agents / chemistry
  • Cryoprotective Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship
  • TRPM Cation Channels / agonists*
  • TRPM Cation Channels / metabolism

Substances

  • Amides
  • Cryoprotective Agents
  • TRPM Cation Channels
  • TRPM8 protein, human